MetaCap

CollPlant Biotechnologies Cash Flow Statement

NASDAQ: OPHIHealth CareIndustrial SpecialtiesUSD

3.13-0.08 (-2.49%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

CollPlant Biotechnologies free cash flow

In fiscal 2025, CollPlant Biotechnologies generated -$9.4 million of operating cash flow and spent $28,000 on capital expenditures. That left free cash flow of -$9.4 million, a free-cash-flow margin of -398.4% of revenue.

Summary generated from market data by MetaCap's automated system. Methodology

CollPlant Biotechnologies cash flow statement (annual)

CollPlant Biotechnologies annual cash flow statement
Fiscal year (USD)FY 20252025-12-31FY 20242024-12-31FY 20232023-12-31FY 20222022-12-31FY 20212021-12-31FY 20202020-12-31FY 20192019-12-31FY 20182018-12-31FY 20172017-12-31
Net Income-11.49M-16.61M-7.02M-16.93M237.00K-5.77M11.16M-6.25M-6.05M
Net Income growth (YoY)———-7241.35%—-151.72%———
Depreciation & Amortization912.00K1.04M1.10M1.08M773.00K660.00K539.00K342.00K230.00K
Stock-Based Compensation999.00K1.72M1.94M2.17M1.60M1.67M1.13M1.43M956.00K
Change in Working Capital426.00K671.00K1.13M477.00K1.20M-1.12M247.00K-1.15M—
Operating Cash Flow-9.42M-14.09M-2.76M-13.70M2.50M-4.45M-5.70M-1.22M-4.97M
Capital Expenditures-28.00K-483.00K-954.00K-1.27M-1.43M-437.00K-1.49M-832.00K-127.00K
Investing Cash Flow-27.00K-539.00K-1.16M28.92M-31.56M-519.00K-1.46M-832.00K-127.00K
Debt Issued———————58.00K—
Debt Repaid—————-24.00K-20.00K-12.00K-70.00K
Financing Cash Flow3.10M9.00K1.11M1.87M38.76M4.46M5.41M2.75M9.11M
Net Change in Cash-6.32M-14.77M-3.19M16.49M9.85M-445.00K-1.75M704.00K4.01M
Free Cash Flow-9.45M-14.58M-3.72M-14.97M1.07M-4.89M-7.19M-2.05M-5.09M

This table shows 9 annual periods of CollPlant Biotechnologies's cash flow statement, from FY 2025 back to FY 2017, across 12 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow OPHI's reporting calendar. What is a cash flow statement?

More financial data